PW Medtech Group (HKSE:01358) Net Income From Continuing Operations : HK$206.4 Mil (TTM As of Dec. 2024)

View and export this data going back to 2013. Start your Free Trial

What is PW Medtech Group Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. PW Medtech Group's net income from continuing operations for the six months ended in Dec. 2024 was HK$105.6 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Dec. 2024 was HK$206.4 Mil.

PW Medtech Group Net Income From Continuing Operations Historical Data

The historical data trend for PW Medtech Group's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PW Medtech Group Net Income From Continuing Operations Chart

PW Medtech Group Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Income From Continuing Operations

Get a 7-Day Free Trial

742.79

903.00

176.16

252.74

245.30

PW Medtech Group Semi-Annual Data
	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Net Income From Continuing Operations	Get a 7-Day Free Trial															64.08	105.96	118.29	100.81	105.58

PW Medtech Group Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$206.4 Mil.

PW Medtech Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » PW Medtech Group Ltd (HKSE:01358) » Definitions » Net Income From Continuing Operations

Comparable Companies

Traded in Other Exchanges

PWE:Germany

Address

No. 23 Panlong West Road, Building 1, Pinggu District, Beijing, CHN, 101204

Website

https://www.pwmedtech.com

PW Medtech Group Ltd is a medical device company with a focus on fast-growing and high-margin segments of China's medical device industry. The company is engaged in the research and development, manufacturing, and sale of the infusion set, intravenous cannula products, and insulin needles. Its products include non-PVC-based infusion sets, precision filter infusion sets, light-resistant infusion sets, intravenous cannula products, and insulin needles and pens. The company operates through three business segments namely Infusion Set Business; Blood Purification Business; and Regenerative Medical Biomaterials Business. It generates maximum revenue from Blood Purification Business. Geographically, it operates in China, North America, India and Others.

Executives

Right Faith Holdings Limited	2101 Beneficial owner
Chan Marc	2201 Interest of corporation controlled by you
Cross Mark Limited	2101 Beneficial owner
Liu Yufeng	2201 Interest of corporation controlled by you
Zhang Zaixian	2202 Interest of your spouse
Fil Limited	2201 Interest of corporation controlled by you
Pandanus Associates Inc.	2201 Interest of corporation controlled by you
Pandanus Partners L.p.	2201 Interest of corporation controlled by you
Fidelity China Special Situations Plc	2101 Beneficial owner

PW Medtech Group Headlines

No Headlines